» Articles » PMID: 32434708

SARS-CoV-2-specific Antibody Detection in Healthcare Workers in Germany with Direct Contact to COVID-19 Patients

Abstract

Background: The novel coronavirus SARS-CoV-2 is associated with a severe respiratory manifestation, COVID-19, and presents a challenge for healthcare systems worldwide. Healthcare workers are a vulnerable cohort for SARS-CoV-2 infection due to frequent and close contact to patients with COVID-19.

Study Design: Serum samples from 316 healthcare workers of the University Hospital Essen, Germany were tested for SARS-CoV-2-IgG antibodies. A questionnaire was used to collect demographic and clinical data. Healthcare workers were grouped depending on the frequency of contact to COVID-19 patients in high-risk-group (n = 244) with daily contact to known or suspected SARS-CoV-2 positive patients, intermediated-risk-group (n = 37) with daily contact to patients without known or suspected SARS-CoV-2 infection at admission and low-risk-group (n = 35) without patient contact.

Results: In 5 of 316 (1.6 %) healthcare workers SARS-CoV-2-IgG antibodies could be detected. The seroprevalence was higher in the intermediate-risk-group vs. high-risk-group (2/37 (5.4 %) vs. 3/244 (1.2 %), p = 0.13). Four of the five subject were tested negative for SARS-CoV-2 via PCR. One (20 %) subject was not tested via PCR since he was asymptomatic.

Conclusion: The overall seroprevalence of SARS-CoV-2 in healthcare workers of a tertiary hospital in Germany is low (1.6 %). The data indicate that the local hygiene standard might be effective.

Citing Articles

COVID-19 IgG seropositivity and its determinants in occupational groups of varying infection risks in two Andean cities of Ecuador before mass vaccination.

Leon-Rojas J, Arias-Erazo F, Jimenez-Arias P, Recalde-Navarrete R, Guevara A, Coloma J PLoS One. 2024; 19(8):e0309466.

PMID: 39208200 PMC: 11361580. DOI: 10.1371/journal.pone.0309466.


Frequency of SARS-CoV-2 Infections among Healthcare Workers in Germany: 3-Year Follow-Up Study.

Stammkotter C, Thummler L, Korth J, Marenbach B, Brass P, Horn P Infect Dis Rep. 2024; 16(4):615-627.

PMID: 39051247 PMC: 11270172. DOI: 10.3390/idr16040047.


SARS-CoV-2 active infection and antibodies amongst health personnel during the outbreak in Cameroon: Strengthening the health system for response to future public health emergencies.

Ngomtcho S, Akenji B, Tchio-Nighie K, Fokam J, Guenou E, NsaAmang Eyebe C PLoS One. 2024; 19(5):e0304477.

PMID: 38820301 PMC: 11142533. DOI: 10.1371/journal.pone.0304477.


The dynamics and determinants of specific systemic and mucosal antibody responses to SARS-CoV-2 in three adult cohorts in the Ecuadorian Andes: a study protocol.

Leon-Rojas J, Veloz T, Teran J, Perez M, Arias-Erazo F, Villacis L F1000Res. 2024; 11:1392.

PMID: 38434000 PMC: 10905138. DOI: 10.12688/f1000research.126577.2.


[SARS-CoV-2 Exposure and Seroprevalence of SARS-CoV-2 Antibodies among Medical Students in the First Phase of the Pandemic 2020-2021].

Landmesser P, Weissbrich B, Peter-Kern M, Krone M, Liese J, Streng A Gesundheitswesen. 2024; 86(4):311-314.

PMID: 38181814 PMC: 11003243. DOI: 10.1055/a-2183-7279.


References
1.
Wu J, Liang J, Zhou H, Peng F, Wang B, Jiang W . Clinical Features and Outcomes of Asymptomatic Cases of SARS-CoV-2 Infection. J Infect. 2020; 81(1):e102-e103. PMC: 7179485. DOI: 10.1016/j.jinf.2020.04.027. View

2.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

3.
Perera R, Mok C, Tsang O, Lv H, Ko R, Wu N . Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Euro Surveill. 2020; 25(16). PMC: 7189648. DOI: 10.2807/1560-7917.ES.2020.25.16.2000421. View

4.
Kwok K, Lai F, Wei W, Wong S, Tang J . Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries. J Infect. 2020; 80(6):e32-e33. PMC: 7151357. DOI: 10.1016/j.jinf.2020.03.027. View

5.
Weissman D, de Perio M, Radonovich Jr L . COVID-19 and Risks Posed to Personnel During Endotracheal Intubation. JAMA. 2020; 323(20):2027-2028. PMC: 7484167. DOI: 10.1001/jama.2020.6627. View